In the November 2003 issue of the ARCHIVES, William C. Stewart and the ISV-205 Study Group1 reported on the use of prophylactic topical diclofenac, contained in a proprietary formulation, for preventing steroid-induced intraocular pressure (IOP) elevation. I believe that the problem of steroid-induced glaucoma is real and growing, and I commend the authors for tackling this difficult issue with an innovative product. Nevertheless, the study’s conclusions do not seem supported by the available data.
Kahana A. Prevention of Steroid-Induced Intraocular Pressure Elevation. Arch Ophthalmol. 2005;123(7):1019-1020. doi:10.1001/archopht.123.7.1019